Clinical implication of VEGF serum levels in cirrhotic patients with or without portal hypertension

doi:10.3748/wjg.v5.i4.296

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 4

This Article

(0)

(4616)

(4)

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Original Article

World J Gastroenterol. Aug 15, 1999; 5(4): 296-300
Published online Aug 15, 1999. doi: 10.3748/wjg.v5.i4.296

Full Size Figure Download Figure

Figure 1 Serum VEGF levels of patients with liver cirrhosis, healthy controls and acute hepatitis. The mean serum level of the cirrhotic patients was significantly lower than that of healthy controls and acute hepatitis patients (P < 0.01, P < 0.02), respectively.

Citation: Nimer A, M P, D G, Y B, G S. Clinical implication of VEGF serum levels in cirrhotic patients with or without portal hypertension. World J Gastroenterol 1999; 5(4): 296-300
URL: https://www.wjgnet.com/1007-9327/full/v5/i4/296.htm
DOI: https://dx.doi.org/10.3748/wjg.v5.i4.296

Nimer A, M P, D G, Y B, G S. Clinical implication of VEGF serum levels in cirrhotic patients with or without portal hypertension. World J Gastroenterol 1999; 5(4): 296-300 [PMID: 11819451 DOI: 10.3748/wjg.v5.i4.296]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.